Navigation Links
Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card
Date:11/23/2009

SAN DIEGO, Nov. 23 /PRNewswire/ -- Victory Pharma, Inc. ("Victory") announced today the launch of NAPRELAN® Dose Card, a further extension of Victory's NAPRELAN franchise.

NAPRELAN Dose Card is designed for patients who require relief from mild to moderate pain and inflammation associated with primary dysmenorrhea and acute tendinitis and bursitis. It is also designed for patients suffering from rheumatoid arthritis or osteoarthritis who may be receiving other therapies and need additional anti-inflammatory/analgesic activity for a limited time. The Dose Card provides a ten day, tapered dose regimen in a single blister pack, with three days of NAPRELAN therapy at the maximum daily dose of 1,500 mg (i.e., two 750 mg tablets), followed by a taper to 1,000 mg per day (two 500 mg tablets) for an additional seven days of therapy.

Commenting on NAPRELAN Dose Card, Victory's Chief Executive Officer Matthew Heck stated, "This product concept is the result of substantial input from our clinical advisors and other members of the pain management community. It was designed to enable healthcare providers to treat pain and inflammation aggressively for a limited period of time and then taper NAPRELAN back to a standard dosage strength. This customized dosage regimen in a single prescription and product configuration will aid in patient compliance. We are excited about the prospects for NAPRELAN Dose Card based upon market feedback."

Victory will promote NAPRELAN Dose Card through its 160 person U.S. field sales organization.

About Victory Pharma

Founded in 2003, Victory Pharma, Inc. is a privately held specialty pharmaceutical company headquartered in San Diego, CA focused on acquiring, developing, and marketing products to treat pain and related conditions. Victory markets its lead product, NAPRELAN® (naproxen sodium) Controlled-Release Tablets and other pain products to pain management specialists, rheumatologists, orthopedic surgeons, and selected primary care physicians through its physician office-based field sales force. Victory is also developing proprietary products for the treatment of chronic pain and common opioid-induced side effects. Further information regarding Victory Pharma is available at www.victorypharma.com.

NAPRELAN ® is a trademark of Elan Corporation, plc.

SOURCE Victory Pharma, Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers notch a victory toward new kind of cancer drug
2. Stupak Amendment Passes in Final House Health Care Bill. A First Step to Victory, but Many Battles Ahead. We Must Rejoice With Caution.
3. Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers; $1 Increase Gives State Second Highest Cigarette Tax in the Nation
4. Mother & Daughter Celebrate Victory Over Meth
5. District of Columbia Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
6. Victory Pharma, Inc. Announces FDA Accepts MGX006 NDA for Review
7. President Obama Delivers Historic Victory for Americas Kids and Health over Tobacco
8. American College of Chest Physicians Celebrates the Nations Victory for Tobacco Control
9. Mississippi Tobacco Tax Increase is a Victory for Kids and Taxpayers
10. Victory! Colombian Government Cuts Price of Abbotts Lifesaving AIDS Drug Kaletra 55%, Says AHF
11. Hawaii Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... 28, 2017 , ... Roxanna Cross will host a key ... Annual RISE Nashville Summit. RISE Nashville is the healthcare industry’s premier event addressing ... The discussion will include best practices for accurate identification and capture of population ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... Healing and Spiritual Awakening, is happy to announce her “Spring Rejuvenation in ... body, these individual customized retreats offer the winter-weary soul an excellent opportunity to ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... an overview on laser diffraction analysis as a tool to characterize particle size ... and potential to obtain improved results and novel scientific findings. It describes methods ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... therapy, is proud to announce a new informational post on robotic hair transplantation. ... Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation (FUT) can sound similar. ...
(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... ... in 2011 the lab became the world’s first to be ISO/IEC 17025:2005 INAB ... (cat allergen) analysis. , ISO/IEC 17025:2005 is the globally recognised standard that sets ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... -- Clarivate Analytics marks the passing of one if its founding fathers, Dr. ... science in the service of scientific and scholarly research. A pioneer in ... that revolutionized the way researchers work with the literature, Garfield passed away ... ... Dr. Eugene Garfield, ...
(Date:2/28/2017)... This report provides all the information you ... and activities since 2010. Download the full ... Deals and Alliance since 2010 report provides an in-depth ... world,s leading life sciences companies. On demand ... of the most up to date deal and company ...
(Date:2/28/2017)... Fourth-quarter 2016 revenues of $1,242 million brings ... of guidance Company reports ... associated with the write-down of goodwill and intangible assets ... Fourth-quarter reported $14.96 diluted (GAAP) ... $14.48 diluted (GAAP) loss per share from continuing operations ...
Breaking Medicine Technology: